Understanding GLP-1 Inhibitors By now, most of us are familiar with GLP-1 medications like Ozempic (semaglutide), Wegovy (semaglutide), and Monjourno (tirzepatide), commonly used to treat type 2 diabetes and now weight loss
Now and then, you'll come across a paper like this one that claims to prove spot reduction in bodily fat
Important safety considerations include risk of pancreatitis (stop treatment and seek urgent care if severe persistent abdominal pain radiating to the back occurs), gallbladder disease , diabetic retinopathy complications (especially with rapid improvement in blood glucose control), and risk of acute kidney injury with dehydration
American Diabetes Association Clinical guidance on metabolic treatment monitoring and patient safety considerations
Algunos pacientes pueden notar cambios a los pocos meses, pero la prdida mxima suele alcanzarse cerca del final del primer ao